Abstract
TRPML1 (mucolipin 1, also known as MCOLN1) is predicted to be an intracellular late endosomal and lysosomal ion channel protein that belongs to the mucolipin subfamily of transient receptor potential (TRP) proteins1,2,3. Mutations in the human TRPML1 gene cause mucolipidosis type IV disease (ML4)4,5. ML4 patients have motor impairment, mental retardation, retinal degeneration and iron-deficiency anaemia. Because aberrant iron metabolism may cause neural and retinal degeneration6,7, it may be a primary cause of ML4 phenotypes. In most mammalian cells, release of iron from endosomes and lysosomes after iron uptake by endocytosis of Fe3+-bound transferrin receptors6, or after lysosomal degradation of ferritin–iron complexes and autophagic ingestion of iron-containing macromolecules6,8, is the chief source of cellular iron. The divalent metal transporter protein DMT1 (also known as SLC11A2) is the only endosomal Fe2+ transporter known at present and it is highly expressed in erythroid precursors6,9. Genetic studies, however, suggest the existence of a DMT1-independent endosomal and lysosomal Fe2+ transport protein9. By measuring radiolabelled iron uptake, by monitoring the levels of cytosolic and intralysosomal iron and by directly patch-clamping the late endosomal and lysosomal membrane, here we show that TRPML1 functions as a Fe2+ permeable channel in late endosomes and lysosomes. ML4 mutations are shown to impair the ability of TRPML1 to permeate Fe2+ at varying degrees, which correlate well with the disease severity. A comparison of TRPML1-/-ML4 and control human skin fibroblasts showed a reduction in cytosolic Fe2+ levels, an increase in intralysosomal Fe2+ levels and an accumulation of lipofuscin-like molecules in TRPML1-/- cells. We propose that TRPML1 mediates a mechanism by which Fe2+ is released from late endosomes and lysosomes. Our results indicate that impaired iron transport may contribute to both haematological and degenerative symptoms of ML4 patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Iron-induced cytotoxicity mediated by endolysosomal TRPML1 channels is reverted by TFEB
Cell Death & Disease Open Access 16 December 2022
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Venkatachalam, K., Hofmann, T. & Montell, C. Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. J. Biol. Chem. 281, 17517–17527 (2006)
Clapham, D. E. TRP channels as cellular sensors. Nature 426, 517–524 (2003)
Nilius, B., Owsianik, G., Voets, T. & Peters, J. A. Transient receptor potential cation channels in disease. Physiol. Rev. 87, 165–217 (2007)
Bassi, M. T. et al. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet. 67, 1110–1120 (2000)
Sun, M. et al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9, 2471–2478 (2000)
Hentze, M. W., Muckenthaler, M. U. & Andrews, N. C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285–297 (2004)
Lee, D. W., Andersen, J. K. & Kaur, D. Iron dysregulation and neurodegeneration: the molecular connection. Mol. Interv. 6, 89–97 (2006)
Kidane, T. Z., Sauble, E. & Linder, M. C. Release of iron from ferritin requires lysosomal activity. Am. J. Physiol. Cell Physiol. 291, C445–C455 (2006)
Gunshin, H. et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 115, 1258–1266 (2005)
Pryor, P. R., Reimann, F., Gribble, F. M. & Luzio, J. P. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 7, 1388–1398 (2006)
Xu, H., Delling, M., Li, L., Dong, X. & Clapham, D. E. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice. Proc. Natl Acad. Sci. USA 104, 18321–18326 (2007)
Di Palma, F. et al. Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc. Natl Acad. Sci. USA 99, 14994–14999 (2002)
Altarescu, G. et al. The neurogenetics of mucolipidosis type IV. Neurology 59, 306–313 (2002)
Goldin, E. et al. Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IV. Hum. Mutat. 24, 460–465 (2004)
Bargal, R., Goebel, H. H., Latta, E. & Bach, G. Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics 33, 199–202 (2002)
Kress, G. J., Dineley, K. E. & Reynolds, I. J. The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J. Neurosci. 22, 5848–5855 (2002)
Petrat, F., de Groot, H. & Rauen, U. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. Arch. Biochem. Biophys. 376, 74–81 (2000)
Goldin, E., Blanchette-Mackie, E. J., Dwyer, N. K., Pentchev, P. G. & Brady, R. O. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediatr. Res. 37, 687–692 (1995)
Kurz, T., Terman, A., Gustafsson, B. & Brunk, U. T. Lysosomes in iron metabolism, ageing and apoptosis. Histochem. Cell Biol. 129, 389–406 (2008)
Chen, C. S., Bach, G. & Pagano, R. E. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl Acad. Sci. USA 95, 6373–6378 (1998)
Zeevi, D. A., Frumkin, A. & Bach, G. TRPML and lysosomal function. Biochim. Biophys. Acta. 1772, 851–858 (2007)
Andrews, N. C. & Schmidt, P. J. Iron homeostasis. Annu. Rev. Physiol. 69, 69–85 (2007)
Cerny, J. et al. The small chemical vacuolin-1 inhibits Ca2+-dependent lysosomal exocytosis but not cell resealing. EMBO Rep. 5, 883–888 (2004)
Saito, M., Hanson, P. I. & Schlesinger, P. Luminal chloride-dependent activation of endosome calcium channels: patch clamp study of enlarged endosomes. J. Biol. Chem. 282, 27327–27333 (2007)
Xu, H., Jin, J., DeFelice, L. J., Andrews, N. C. & Clapham, D. E. A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calcium entry pathway. PLoS Biol. 2, E50 (2004)
Acknowledgements
This work is supported by start-up funds to H.X. from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan. We thank U. Brunk, M. Saito, R. Hume, C. Duan, M. Akaaboune, J. Kuwada, S. Low, S. Punthambaker and S. Dellal for assistance, and D. Clapham, N. Andrews, L. DeFelice, L. Yue, D. Ren, C. Jiang and S. Xu for comments on an earlier version of the manuscript. We also thank K. Kiselyov for sharing his unpublished results on lysosomal iron staining of ML4 cells. We appreciate the encouragement and helpful comments from other members of the Xu laboratory.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-17 with Legends, Supplementary Discussion and Supplementary References. (PDF 5716 kb)
Rights and permissions
About this article
Cite this article
Dong, XP., Cheng, X., Mills, E. et al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455, 992–996 (2008). https://doi.org/10.1038/nature07311
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature07311
This article is cited by
-
Iron-induced cytotoxicity mediated by endolysosomal TRPML1 channels is reverted by TFEB
Cell Death & Disease (2022)
-
HIV-1 gp120-Induced Endolysosome de-Acidification Leads to Efflux of Endolysosome Iron, and Increases in Mitochondrial Iron and Reactive Oxygen Species
Journal of Neuroimmune Pharmacology (2022)
-
Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy
Basic Research in Cardiology (2022)
-
A DNA-based voltmeter for organelles
Nature Nanotechnology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.